Virginia K. Langmuir

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 529 citations

Medicine, Oncology, Pharmacology +12

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies

Glen J. Weiss, Jeffrey R. Infante, E. Gabriela Chiorean et al. · Clinical Cancer Research · 2011 · 153 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer

Adrian M. Jubb, Kathy D. Miller, Hope S. Rugo et al. · Clinical Cancer Research · 2011 · 99 citations · Full text

Medicine, Oncology, Pharmacology +15

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine

Tudor–Eliade Ciuleanu, Alexander V. Pavlovsky, G. Bodoky et al. · European Journal of Cancer · 2009 · 93 citations

Medicine, Oncology, Pharmacology +9